DSE:RUPALILIFE

Rupali Life Insurance Company Limited announcements

325 Dhaka Stock Exchange announcements for Rupali Life Insurance Company Limited (RUPALILIFE) since 2009: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2026 (19).

  1. Dividend Disbursement

    The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2025 to the respective shareholders.

  2. Q3 Financials

    (Q3 Un-audited): As per life revenue account of the company for July to September, 2026, excess of total expenses including claims over total income (deficit) was BDT 65.53 million as against excess of total expenses including claims over total income (deficit) of BDT 28.91 million in the corresponding previous period of 2025. Whereas as per life revenue account of the company for January to September, 2026, (cont.) (Continuation news of RUPALILIFE): excess of total expenses including claims over total income (deficit) was BDT 217.59 million as against excess of total expenses including claims over total income (deficit) of BDT 177.98 million in the corresponding previous period of 2025. Accordingly, Balance of Life Insurance Fund was BDT 4,789.89 million as on September 30, 2026 as against BDT 4,768.42 million as on September 30, 2025 resulting a net increase of BDT 21.46 million. (end)

  3. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended September 30, 2026.

  4. Sale Confirmation of a Sponsor

    Mrs. Kamrunnessa Jharna, a Sponsor of the Company has completed her sale of 313,509 shares of the Company at the prevailing market price through Dhaka Stock Exchange PLC. (DSE) as per the declaration disseminated on 23.08.2026.

  5. Credit Rating Result

    Credit Rating Agency of Bangladesh Limited (CRAB) has assigned Surveillance rating of the Company as "A2" in the long term along with Stable outlook based on audited financial statements and actuarial valuation reports up to December 31, 2025, unaudited financial statements as of June 30, 2026 and other information up to the date of rating declaration.

  6. Link of AGM

    Refer to their earlier news disseminated by DSE on 21.07.2026 regarding dividend declaration, the company has provided the link of AGM which is as follows: https://rupalilifeinsurance.bdvirtualagm.com

  7. Update of Information

    The company has requested the Concerned Brokerage House/DPs to provide the statement (both of hard copy & soft copy) with details of their margin loan holders entitled to final dividend 2025 on or before September 13, 2026. The Statement should include shareholders name, BO ID No., client wise shareholding position, contact person etc. The record date was 20 August 2026. Please send the soft copy to the email address: [email protected] and contact the following number: 01847133722.

  8. Sale Declaration of a Sponsor

    Mrs. Kamrunnessa Jharna, a Sponsor of the Company has expressed her intention to sell entire holding of 313,509 shares of the Company at the prevailing market price in the Public Market through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.

  9. Resumption after Record Date

    Trading of the shares of the company will resume on 23-Aug-2026.

  10. Name Change of the Company

    Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'Rupali Life Insurance PLC.' instead of 'Rupali Life Insurance Company Limited' with effect from August 23, 2026. Other information (except name) will remain unchanged.

  11. Suspension for Record Date

    Trading of the shares of the company will remain suspended on record date i.e., 20-Aug-2026.

  12. Spot News

    Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 18.08.2026 to 19.08.2026 and trading of the shares will remain suspended on record date i.e., 20.08.2026.

  13. Qualified Opinion and Emphasis of Matters

    The auditor of the company has given the Qualified Opinion and Emphasis of Matters paragraph in the auditor's report for the year ended December 31, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/RUPALIINS_2025.pdf

  14. Dividend Declaration

    The Board of Directors has recommended 12% Cash Dividend for the year ended December 31, 2025. Date of AGM: 24.09.2026, Time: 10:00 AM, Venue: Through Digital Platform (Link will be notified later). Record Date: 20.08.2026.

  15. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (21.07.2026) following its corporate declaration.

  16. Q1 Financials

    (Q1 Un-audited): As per life revenue account of the company for January to March, 2026, excess of total expenses including claims over total income (deficit) was BDT 70.95 million as against excess of total expenses including claims over total income over (deficit) of BDT 150.55 million in the corresponding previous period of 2025. (cont.) (Continuation news of RUPALILIFE): Balance of Life Insurance Fund was BDT 4,937.59 million as on March 31, 2026 as against BDT 4,797.41 million as on March 31, 2025 resulting a net increase of BDT 140.18 million. (end)

  17. Q2 Financials

    (Q2 Un-audited): As per life revenue account of the company for April to June, 2026, excess of total expenses including claims over total income (deficit) was BDT 81.10 million as against excess of total income over total expenses including claims (surplus) of BDT 1.48 million in the corresponding previous period of 2025. Whereas as per life revenue account of the company for January to June, 2026, excess of total expenses including claims over total income (deficit) was BDT 152.06 million (cont.) (Continuation news of RUPALILIFE): as against excess of total expenses including claims over total income over (deficit) of BDT 149.07 million in the corresponding previous period of 2025. Accordingly, Balance of Life Insurance Fund was BDT 4,855.73 million as on June 30, 2026 as against BDT 4,798.13 million as on June 30, 2025 resulting a net increase of BDT 57.60 million. (end)

  18. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 20, 2026 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2025.

  19. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 20, 2026 at 3:00 pm to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended March 31, 2026 and Second Quarter (Q2) period ended June 30, 2026 respectively.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.